Share this to:

Support & Insight for the Autumn of Life

“For the first time I think we have a chance to really change the course of Alzheimer’s.”

VIDEO:

“For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading the “A4 Clinical Trial” to see if a drug called Solanezumab can slow down or even prevent Alzheimer’s disease. CBS News reports.


More on the A4 Clinical Trial:


SOURCE:

  • CBS News in Washington
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

laboratory, analysis, chemistry
FDA Okays Trial of Alzheimer's Pill with Unique Mechanism
The new Alzheimer's injections Aduhelm and Lecanemab offer hope. Now, Mastinimab is trying to break through to the ne...
140302-silver.jpeg
Nanosilver Warning
Alzheimer's is characterized by an overproduction of free radicals in cells. That's why incredibly tiny "nanoparticl...
Plaques.jpeg
Swelling Along Brain’s Axons May be True Culprit in Alzheimer’s

Books

Amazon Books
0
Would love your thoughts, please comment.x
()
x
News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter